Neovacs raised €2.0M in a funding round in Aug 2021. The company is based in France. Investors in the round: European High Growth Opportunities Securitization Fund. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €2.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
